| Cobalt (iii)-catalyzed C–H halogenation of 6-arylpurines: facile entry into arylated, sulfenylated and alkoxylated 6-arylpurines AB Pawar, DM Lade Organic & Biomolecular Chemistry 14 (12), 3275-3283, 2016 | 72 | 2016 |
| Cp* Co (III)-catalyzed C–H/N–N functionalization of arylhydrazones for the synthesis of isoquinolines AB Pawar, D Agarwal, DM Lade The Journal of Organic Chemistry 81 (22), 11409-11415, 2016 | 60 | 2016 |
| Total synthesis of lamellarin D trimethyl ether, lamellarin D, and lamellarin H DM Lade, AB Pawar, PS Mainkar, S Chandrasekhar The Journal of Organic Chemistry 82 (9), 4998-5004, 2017 | 59 | 2017 |
| Cp* Co (III)-catalyzed vinylic C–H bond activation under mild conditions: expedient pyrrole synthesis via (3+ 2) annulation of enamides and alkynes DM Lade, AB Pawar Organic Chemistry Frontiers 3 (7), 836-840, 2016 | 59 | 2016 |
| Cp* Ir (III)-catalyzed C–H/N–H functionalization of sulfoximines for the synthesis of 1, 2-benzothiazines at room temperature YN Aher, DM Lade, AB Pawar Chemical Communications 54 (49), 6288-6291, 2018 | 57 | 2018 |
| Cp* Ir (III)-Catalyzed C–H/O–H Functionalization of Salicylaldehydes for the Synthesis of Chromones at Room Temperature DM Lade, YN Aher, AB Pawar The Journal of Organic Chemistry 84 (14), 9188-9195, 2019 | 33 | 2019 |
| Strategies towards the synthesis of anti-tuberculosis drugs HB Rode, DM Lade, R Grée, PS Mainkar, S Chandrasekhar Organic & Biomolecular Chemistry 17 (22), 5428-5459, 2019 | 32 | 2019 |
| A Facile synthesis and antituberculosis properties of almazole D and its enantiomer DM Lade, VS Krishna, D Sriram, HB Rode ChemistrySelect 2 (3), 1250-1252, 2017 | 18 | 2017 |
| Design and synthesis of improved active-site SHP2 inhibitors with anti-breast cancer cell effects DM Lade, R Nicoletti, J Mersch, YM Agazie European Journal of Medicinal Chemistry 247, 115017, 2023 | 9 | 2023 |
| Targeting SHP2 with an Active Site Inhibitor Blocks Signaling and Breast Cancer Cell Phenotypes DM Lade, YM Agazie ACS bio & med Chem Au 3 (5), 418-428, 2023 | 6 | 2023 |
| Development of a more penetrating HER2-positive Breast Cancer Tumor Model and Testing Efficacy of SHP2 Targeting with an Active-Site Inhibitor Y AGAZIE, J Mersch, D Lade, P Lockman | | 2025 |
